Bernhard Keppler

Personal Home Page

http://translate.google.com/translate?hl=en&u=http://www.dieuniversitaet-online.at/beitraege/news/bernhard-keppler-neuer-vorsitzender-des-upv/10.html

Articles in Scholarly Journals [Incomplete List]

  1. The Complexes [OsCl2(azole)2(dmso)2] and [OsCl2(azole)(dmso)3]: Synthesis, Structure, Spectroscopic Properties and Catalytic Hydration of Chloronitriles
    European Journal of Inorganic Chemistry, vol. 2007, no. 3, pp. 400–411, 2007
  2. Ruthenium(II) Complexes of Thiosemicarbazones: The First Water-Soluble Complex with pH-Dependent Antiproliferative Activity
    European Journal of Inorganic Chemistry, vol. 2007, no. 18, pp. 2870–2878, 2007
  3. Probing the stability of serum protein–ruthenium(III) drug adducts in the presence of extracellular reductants using CE
    ELECTROPHORESIS, vol. 28, no. 13, pp. 2235–2240, 2007
  4. Application of micellar and microemulsion electrokinetic chromatography for characterization of gallium(III) complexes of pharmaceutical significance
    Journal of Separation Science, vol. 30, no. 3, pp. 399–406, 2007
  5. Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)
    Biochemical Pharmacology, vol. 73, no. 12, pp. 1873–1886, 2007
  6. Characterization of interactions between human serum albumin and tumor-inhibiting amino alcohol platinum(II) complexes using capillary electrophoresis
    Journal of Chromatography A, vol. 1155, no. 2, pp. 218–221, 2007
  7. First Example of the Solid-State Thermal Cyclometalation of Ligated Benzophenone Imine Giving Novel Luminescent Platinum(II) Species
    Inorganic Chemistry, vol. 46, no. 11, pp. 4469–4482, 2007
  8. The First Ruthenium-Based Paullones: Syntheses, X-ray Diffraction Structures, and Spectroscopic and Antiproliferative Properties in Vitro
    Inorganic Chemistry, vol. 46, no. 9, pp. 3645–3656, 2007
  9. Osmium NAMI-A Analogues: Synthesis, Structural and Spectroscopic Characterization, and Antiproliferative Properties
    Inorganic Chemistry, vol. 46, no. 12, pp. 5023–5033, 2007
  10. Structure-Activity Relationships for NAMI-A-type Complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = Imidazole, Indazole, 1,2,4-Triazole, 4-Amino-1,2,4-triazole, and 1-Methyl-1,2,4-triazole): Aquation, Redox Properties, Protein Binding, and Antiproliferative Activity
    Journal of Medicinal Chemistry, vol. 50, no. 9, pp. 2185–2193, 2007
  11. Gallium(III) and Iron(III) Complexes of a-N-Heterocyclic Thiosemicarbazones: Synthesis, Characterization, Cytotoxicity, and Interaction with Ribonucleotide Reductase
    Journal of Medicinal Chemistry, vol. 50, no. 6, pp. 1254–1265, 2007
  12. Mass spectrometric analysis of ubiquitin?platinum interactions of leading anticancer drugs: MALDI versus ESI
    Journal of Analytical Atomic Spectrometry, vol. 22, no. 8, p. 960, 2007
  13. Two new ?onium? fluorosilicates, the products of interaction of fluorosilicic acid with 12-membered macrocycles: structures and spectroscopic properties
    Dalton Transactions, no. 27, p. 2915, 2007
  14. Inorganic Chemistry, vol. 45, no. 5, pp. 1945–1950, 2006
  15. Redox behavior of tumor-inhibiting ruthenium(iii) complexes and effects of physiological reductants on their binding to GMP
    Dalton Transactions, no. 14, p. 1796, 2006
  16. Reversion of Structure-Activity Relationships of Antitumor Platinum Complexes by Acetoxime but Not Hydroxylamine Ligands
    Molecular Pharmacology, vol. 71, no. 1, pp. 357–365, 2006
  17. Biochemistry, vol. 45, no. 49, pp. 14817–14825, 2006
  18. Chemical Reviews, vol. 106, no. 6, pp. 2224–2248, 2006
  19. Determination of cisplatin and its hydrolytic metabolite in human serum by capillary electrophoresis techniques
    Journal of Chromatography A, vol. 1106, no. 1-2, pp. 75–79, 2006
  20. NCA nucleophilic radiofluorination on substituted benzaldehydes for the preparation of [18F]fluorinated aromatic amino acids
    Applied Radiation and Isotopes, vol. 64, no. 3, pp. 355–359, 2006
  21. Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24)
    Biochemical Pharmacology, vol. 71, no. 4, pp. 426–440, 2006
  22. From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
    Journal of Inorganic Biochemistry, vol. 100, no. 5-6, pp. 891–904, 2006
  23. Preclinical characterization of anticancer gallium(III) complexes: Solubility, stability, lipophilicity and binding to serum proteins
    Journal of Inorganic Biochemistry, 2006
  24. Electrospray ionization mass spectrometric study on the coordination behavior of dacarbazine towards transition metal ions
    Polyhedron, vol. 25, no. 9, pp. 1971–1978, 2006
  25. Metallodrug research and analysis using capillary electrophoresis
    TrAC Trends in Analytical Chemistry, vol. 25, no. 9, pp. 868–875, 2006
  26. Tumorhemmende Metallverbindungen: Entwicklung, Bedeutung und Perspektiven
    Pharmazie in unserer Zeit, vol. 35, no. 2, pp. 118–123, 2006
  27. Platinum group metallodrug-protein binding studies by capillary electrophoresis – inductively coupled plasma-mass spectrometry: A further insight into the reactivity of a novel antitumor ruthenium(III) complex toward human serum proteins
    ELECTROPHORESIS, vol. 27, no. 5-6, pp. 1128–1135, 2006
  28. An Entry to Novel Platinum Complexes: Carboxylation of Dihydroxoplatinum(IV) Complexes with Succinic Anhydride and Subsequent Derivatization
    European Journal of Inorganic Chemistry, vol. 2006, no. 13, pp. 2612–2617, 2006
  29. Bis(2-amino alcohol-κN)dicarboxylatoplatinum(II) Complexes â?? Elegant Synthesis via Ring-Opening of Bis(2-amino alcoholato-κ2N,O)platinum(II) Species with Dicarboxylic Acids
    European Journal of Inorganic Chemistry, vol. 2006, no. 12, pp. 2476–2483, 2006
  30. Synthesis and Characterization of [(1R,2R)-trans-Diaminocyclohexane]platinum(II) Coordinated to Sulfur and Selenium Amino Acids
    European Journal of Inorganic Chemistry, vol. 2006, no. 18, pp. 3746–3752, 2006
  31. 1,1'-Bis(oxazolin-2-yl)ferrocenes: An Investigation of Their Complexation Behavior toward [Pd(?3-allyl)Cl]2
    European Journal of Inorganic Chemistry, vol. 2005, no. 8, pp. 1589–1600, 2005
  32. Cisplatin Damage: Are DNA Repair Proteins Saviors or Traitors to the Cell?
    ChemBioChem, vol. 6, no. 7, pp. 1157–1166, 2005
  33. Determination of binding constants and stoichiometries for platinum anticancer drugs and serum transport proteins by capillary electrophoresis using the Hummel-Dreyer method
    Journal of Separation Science, vol. 28, no. 2, pp. 121–127, 2005
  34. Analysis of anticancer platinum(II)-complexes by microemulsion electrokinetic chromatography: Separation of diastereomers and estimation of octanol-water partition coefficients
    ELECTROPHORESIS, vol. 26, no. 4-5, pp. 878–884, 2005
  35. Bis- and tris-bicyclophosphites of -glucofuranoside. Unexpected catalysis of P(III/V)-oxidation by triethylamine
    Tetrahedron, vol. 61, no. 46, pp. 10943–10950, 2005
  36. Glucose ferrocenyl-oxazolines: Coordination behavior toward [Pd(?-allyl)Cl] studied by ESI-MS
    Journal of Organometallic Chemistry, vol. 690, no. 14, pp. 3301–3308, 2005
  37. Synthesis and structure-activity relationships of mono- and dialkyl-substituted oxaliplatin derivatives
    European Journal of Medicinal Chemistry, vol. 40, no. 11, pp. 1149–1155, 2005
  38. The heterocyclic ruthenium(III) complex KP1019 (FFC14A) causes DNA damage and oxidative stress in colorectal tumor cells
    Cancer Letters, vol. 226, no. 2, pp. 115–121, 2005
  39. Comparative binding of antitumor indazolium [-tetrachlorobis(1-indazole)ruthenate(III)] to serum transport proteins assayed by capillary zone electrophoresis
    Analytical Biochemistry, vol. 341, no. 2, pp. 326–333, 2005
  40. Design, synthesis, physical and chemical characterisation, and biological interactions of lectin-targeted latex nanoparticles bearing Gdâ??DTPA chelates: an exploration of magnetic resonance molecular imaging (MRMI)
    Histochemistry and Cell Biology, vol. 123, no. 3, pp. 283–301, 2005
  41. Synthesis, Cytotoxicity, and Structure-Activity Relationships of New Oxaliplatin Derivatives
    Monatshefte für Chemie - Chemical Monthly, vol. 136, no. 5, pp. 693–700, 2005
  42. Inorganic Chemistry, vol. 44, no. 1, pp. 122–132, 2005
  43. Synthesis and in vitro Antitumor Potency of (Cyclohexane-1,2-Diamine)Platinum(II) Complexes with Aminotris(Methylenephosphonic Acid) as Bone-Seeking Ligand
    Bioinorganic Chemistry and Applications, vol. 3, no. 3-4, pp. 179–190, 2005
  44. Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches
    Current Medicinal Chemistry, vol. 12, no. 18, pp. 2075–2094, 2005
  45. Journal of Medicinal Chemistry, vol. 48, no. 8, pp. 2831–2837, 2005
  46. Inorganic Chemistry, vol. 44, no. 19, pp. 6704–6716, 2005
  47. Isomeric [RuCl2(dmso)2(indazole)2] complexes: ruthenium(ii)-mediated coupling reaction of acetonitrile with 1H-indazole
    Dalton Transactions, no. 14, p. 2355, 2005
  48. Tumour-inhibiting platinum(ii) complexes with aminoalcohol ligands: biologically important transformations studied by micellar electrokinetic chromatography, nuclear magnetic resonance spectroscopy and mass spectrometry
    The Analyst, vol. 130, no. 10, p. 1383, 2005
  49. Two dimensional separation schemes for investigation of the interaction of an anticancer ruthenium(iii) compound with plasma proteins
    Journal of Analytical Atomic Spectrometry, vol. 20, no. 9, p. 856, 2005
  50. Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopy
    Journal of Analytical Atomic Spectrometry, vol. 19, no. 1, p. 46, 2004
  51. Intrinsic and Acquired Forms of Resistance against the Anticancer Ruthenium Compound KP1019 [Indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A)
    Journal of Pharmacology and Experimental Therapeutics, vol. 312, no. 1, pp. 281–289, 2004
  52. Gallium in Cancer Treatment
    Current Topics in Medicinal Chemistry, vol. 4, no. 15, pp. 1575–1583, 2004
  53. Inorganic Chemistry, vol. 43, no. 22, pp. 7083–7093, 2004
  54. Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells
    Journal of Cancer Research and Clinical Oncology, vol. 131, no. 2, pp. 101–110, 2004
  55. On the Coordination Properties of New Bicyclophosphite-Carbohydrates
    Monatshefte für Chemie - Chemical Monthly, vol. 136, no. 2, pp. 137–146, 2004
  56. Synthesis, crystal structure and cytotoxicity of new oxaliplatin analogues indicating that improvement of anticancer activity is still possible
    European Journal of Medicinal Chemistry, vol. 39, no. 8, pp. 707–714, 2004
  57. Synthesis, crystal structure and pH dependent cytotoxicity of (SP-4-2)-bis(2-aminoethanolato-?2N,O)platinum(II) ? a representative of novel pH sensitive anticancer platinum complexes
    Inorganica Chimica Acta, vol. 357, no. 11, pp. 3237–3244, 2004
  58. A comparative study of adduct formation between the anticancer ruthenium(III) compound HInd trans-6RuCl4(Ind)29 and serum proteins
    Journal of Inorganic Biochemistry, vol. 98, no. 6, pp. 1135–1142, 2004
  59. Platinum metallodrug-protein binding studies by capillary electrophoresis-inductively coupled plasma-mass spectrometry: Characterization of interactions between Pt(II) complexes and human serum albumin
    ELECTROPHORESIS, vol. 25, no. 13, pp. 1988–1995, 2004
  60. Analysis of Platinum Adducts with DNA Nucleotides and Nucleosides by Capillary Electrophoresis Coupled to ESI-MS: Indications of Guanosine 5?-MonophosphateO6-N7 Chelation
    ChemBioChem, vol. 5, no. 11, pp. 1543–1549, 2004
  61. Synthesis, Crystal Structure and Biological Characterization of a Novel Palladium(II) Complex with a Coumarin-Derived Ligand
    European Journal of Inorganic Chemistry, vol. 2004, no. 22, pp. 4412–4419, 2004
  62. Crystallographic report: Crystal structure of 1-bromo-1?-[(2S)-N-(1-hydroxy-3-methylbutane-2-yl)]-ferroceneamide
    Applied Organometallic Chemistry, vol. 17, no. 9, pp. 723–724, 2003
  63. Bis(2-aminobutanol)dichloroplatinum(II) Complexes and Their Singly and Doubly Ring-Closed Butanolato Species - Novel Prodrugs for Platinum-Based Antitumour Chemotherapy?
    European Journal of Inorganic Chemistry, vol. 2003, no. 14, pp. 2619–2625, 2003
  64. Capillary electrophoresis in anti-cancer metallodrug research: Advances and future challenges
    ELECTROPHORESIS, vol. 24, no. 1213, pp. 2023–2037, 2003
  65. Tumor-inhibiting platinum(II) complexes with aminoalcohol ligands: Comparison of the mode of action by capillary electrophoresis and electrospray ionization-mass spectrometry
    ELECTROPHORESIS, vol. 24, no. 1213, pp. 2038–2044, 2003
  66. Inorganic Chemistry, vol. 42, no. 8, pp. 2805–2813, 2003
  67. Inorganic Chemistry, vol. 42, no. 19, pp. 6024–6031, 2003
  68. Journal of Medicinal Chemistry, vol. 46, no. 23, pp. 4946–4951, 2003
  69. Recent Developments in the Field of Tumor-Inhibiting Metal Complexes
    Current Pharmaceutical Design, vol. 9, no. 25, pp. 2078–2089, 2003
  70. Synthesis, crystal structures, and electrospray ionisation mass spectrometry investigations of ether- and thioether-substituted ferrocenes
    Dalton Transactions, no. 15, p. 3098, 2003
  71. Novel glucose-ferrocenyl derivatives: synthesis and properties
    New Journal of Chemistry, vol. 26, no. 6, pp. 671–673, 2002
  72. Platinum(iv)-mediated coupling of dione monoximes and nitriles: a novel reactivity pattern of the classic oxime-based chelating ligands
    New Journal of Chemistry, vol. 26, no. 8, pp. 1085–1091, 2002
  73. 1,1,3,3-Tetramethyl-1,3-disila-2-oxa[3]ferrocenophane: improved synthesis and new crystal structure
    Inorganica Chimica Acta, vol. 328, no. 1, pp. 237–240, 2002
  74. Reaction of (SP-4-2)-dichlorobis(2-hydroxyethylamine)platinum(II) with 5'-GMP under simulated physiological conditions, a CZE-ESI-MS study
    Inorganica Chimica Acta, vol. 339, pp. 9–13, 2002
  75. Capillary electrophoresis of platinum-group elements Analytical, speciation and biochemical studies
    Journal of Chromatography A, vol. 945, no. 1-2, pp. 25–44, 2002
  76. Synthesis of ferrocenylglucose phosphonite and bisphosphinite: Pd(II) and Pt(II) complexes, Pd-catalyzed allylic alkylation
    Tetrahedron, vol. 58, no. 42, pp. 8489–8492, 2002
  77. (Aminoethanol)dichloroplatinum(II) complexes: influence of the hydroxyethyl moiety on 5'-GMP and DNA binding, intramolecular stability, the partition coefficient and anticancer activity
    Journal of Inorganic Biochemistry, vol. 88, no. 3-4, pp. 254–259, 2002
  78. Synthesis, structure, spectroscopic and in vitro antitumour studies of a novel gallium(III) complex with 2-acetylpyridine 4N-dimethylthiosemicarbazone
    Journal of Inorganic Biochemistry, vol. 91, no. 1, pp. 298–305, 2002
  79. Application of capillary electrophoresis-mass spectrometry for the investigation of the binding behavior of oxaliplatin to 5’-GMP in the presence of the sulfur-containing amino acid L-methionine
    ELECTROPHORESIS, vol. 23, no. 1, p. 74, 2002
  80. The Intramolecular Ligand-Exchange Reaction of (SP-4-2)-Dichlorobis(2-hydroxyethylamine)platinum(II) and (OC-6-22)-Tetrachlorobis(2-hydroxyethylamine)platinum(IV), a1H and15N,1H-HMQC NMR Study
    European Journal of Inorganic Chemistry, vol. 2001, no. 5, pp. 1145–1149, 2001
  81. [RuCl3ind3] and [RuCl2ind4]: Two New Ruthenium Complexes derived from the Tumor-inhibiting RuIII Compound HInd (OC-6-11)-[RuCl4ind2] (ind = indazole)
    Zeitschrift für anorganische und allgemeine Chemie, vol. 627, no. 2, pp. 261–265, 2001
  82. Reaction monitoring of platinum(II) complex-5?-guanosine monophosphate adduct formation by ion exchange liquid chromatography/electrospray ionization mass spectrometry
    Journal of Mass Spectrometry, vol. 36, no. 7, pp. 742–753, 2001
  83. Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media
    Journal of Biological Inorganic Chemistry, vol. 6, no. 4, pp. 435–445, 2001
  84. Hydrolysis of the tumor-inhibiting ruthenium(III) complexes HIm trans -[RuCl 4 (im) 2 ] and HInd trans -[RuCl 4 (ind) 2 ] investigated by means of HPCE and HPLC-MS
    Journal of Biological Inorganic Chemistry, vol. 6, no. 3, pp. 292–299, 2001
  85. Capillary electrophoretic study of carboplatin and analogues with nucleoside monophosphates, di- and trinucleotides
    Journal of Inorganic Biochemistry, vol. 83, no. 2-3, pp. 181–186, 2001
  86. Comparison of the binding behavior of oxaliplatin, cisplatin and analogues to 5'-GMP in the presence of sulfur-containing molecules by means of capillary electrophoresis and electrospray mass spectrometry
    Journal of Inorganic Biochemistry, vol. 86, no. 4, pp. 691–698, 2001
  87. Investigations into the interaction between tumor-inhibiting ruthenium(III) complexes and nucleotides by capillary electrophoresis
    Journal of Chromatography B: Biomedical Sciences and Applications, vol. 759, no. 1, pp. 81–89, 2001
  88. QUINOLONE ANTIBACTERIAL AGENTS LINKED TO OSTEOTROPIC BISPHOSPHONATE MOIETIES
    Phosphorus, Sulfur, and Silicon and the Related Elements, vol. 170, no. 1, pp. 5–14, 2001
  89. Preparation Of Tetraethyl-4-Hydroxyphenylmethylene-1,1-Bisphosphonate By Hydroxy-De-Diazoniation of The Corresponding Diazonium Salt Of Tetraethyl-4-Aminophenylmethylene-1,1-Bisphosphonate
    Phosphorus, Sulfur, and Silicon and the Related Elements, vol. 165, no. 1, pp. 77–82, 2000
  90. Solvolysis of the Tumor-Inhibiting Ru(III)-Complex trans-Tetrachlorobis(Indazole)Ruthenate(III)
    Metal-Based Drugs, vol. 7, no. 4, pp. 225–232, 2000
  91. Binding of Antitumor Ruthenium(III) Complexes to Plasma Proteins
    Metal-Based Drugs, vol. 7, no. 6, pp. 335–342, 2000
  92. Synthesis of (N,N'-Bis(2-Hydroxyethyl)Ethane-1,2-Diamine)Malonatoplatinum(II) and X-Ray Crystal Structure of the Cis-R,S-Isomer
    Metal-Based Drugs, vol. 7, no. 6, pp. 349–355, 2000
  93. Kinetics of binding properties of 5'-GMP with cisplatin under simulated physiological conditions by capillary electrophoresis
    Journal of Chromatography B: Biomedical Sciences and Applications, vol. 745, no. 1, pp. 211–219, 2000
  94. Studies on the interactions between human serum albumin and trans-indazolium (bisindazole) tetrachlororuthenate(III)
    Journal of Inorganic Biochemistry, vol. 78, no. 4, pp. 341–346, 2000
  95. Is reduction required for antitumour activity of platinum(IV) compounds? Characterisation of a platinum(IV)–nucleotide adduct [enPt(OCOCH3)3(5'-GMP)] by NMR spectroscopy and ESI-MS
    Inorganica Chimica Acta, vol. 300-302, no. 1, pp. 783–789, 2000
  96. Time-dependent interactions of platinum(II) complexes with 5′-GMP under simulated physiological conditions studied by capillary electrophoresis
    Journal of Biological Inorganic Chemistry, vol. 5, no. 4, pp. 498–504, 2000
  97. Investigation of metallodrug–protein interactions by size-exclusion chromatography coupled with inductively coupled plasma mass spectrometry (ICP-MS)
    Analytica Chimica Acta, vol. 387, no. 2, pp. 135–144, 1999
  98. Synthesis of Tumor-Inhibiting Complex Salts Containing the Aniontrans-Tetrachlorobis(indazole)ruthenate(III) and Crystal Structure of the Tetraphenylphosphonium Salt
    European Journal of Inorganic Chemistry, vol. 1999, no. 9, pp. 1551–1555, 1999
  99. Calcium Ions Do Accelerate the DNA Binding of New Antitumor-Active Platinum Aminophosphonate Complexes
    European Journal of Inorganic Chemistry, vol. 1999, no. 10, pp. 1655–1657, 1999
  100. Synthesis and structures of (SP-4-2)-diiodobis(2-hydroxyethylamine)platinum(II), (SP-4-2)-dichlorobis(2-hydroxyethylamine)platinum(II) and (OC-6-22)-bis(2-hydroxyethylamine)tetrachloroplatinum(IV) in the crystal
    Inorganica Chimica Acta, vol. 292, no. 1, pp. 127–130, 1999
  101. Capillary electrophoretic study of cisplatin interaction with nucleoside monophosphates, di- and trinucleotides
    Journal of Chromatography A, vol. 852, no. 1, pp. 337–346, 1999
  102. Studies on the interactions between human serum albumin and imidazolium [-tetrachlorobis(imidazol)ruthenate(III)]
    Journal of Inorganic Biochemistry, vol. 73, no. 3, pp. 123–128, 1999
  103. Effect of cis-, trans-diamminedichloroplatinum(II) and DBP on human serum albumin
    Journal of Inorganic Biochemistry, vol. 77, no. 3-4, pp. 141–146, 1999
  104. Imidazole release from the antitumor-active ruthenium complex imidazolium trans-tetrachlorobis(imidazole) ruthenate(III) by biologically occurring nucleophiles
    Inorganica Chimica Acta, vol. 267, no. 1, pp. 137–141, 1998
  105. Titanium determination in human blood plasma by ICP-OES, longitudinally, and transversally heated Zeeman ETAAS
    Journal of Analytical Atomic Spectrometry, vol. 13, no. 10, pp. 1173–1176, 1998
  106. 1. Phase I and Phase II Study Groups
    Onkologie, vol. 21, no. Suppl. 3, pp. 1–61, 1998
  107. Comparative nephrotoxicity of some antitumour-active platinum and ruthenium complexes in rats
    Journal of Applied Toxicology, vol. 18, no. 2, pp. 93–101, 1998
  108. Overview on bismuth(III) and bismuth(V) complexes with activity against
    Coordination Chemistry Reviews, vol. 163, pp. 345–364, 1997
  109. Darstellung und Struktur von Hexa(4-methoxyphenyl)cyclohexaarsan
    Zeitschrift für anorganische und allgemeine Chemie, vol. 623, no. 1-6, pp. 75–78, 1997
  110. Synthesis of water-soluble ruthenium porphyrins as DNA cleavers and potential cytotoxic agents
    Journal of Biological Inorganic Chemistry, vol. 2, no. 4, pp. 427–432, 1997
  111. Carboxylation of dihydroxoplatinum(IV) complexes with acyl chlorides. Crystal structures of the trans-R,R- and trans-S,S-isomer of (OC-6-33)-bis(1-adamantanecarboxylato)-(cyclohexane-1,2-diamine)dichloroplatinum(IV)
    Inorganica Chimica Acta, vol. 265, no. 1-2, pp. 271–274, 1997
  112. The influence of calcium ions on the DNA binding behaviour of a new platinum(II) compound linked to an amino phosphonic acid*1
    Inorganica Chimica Acta, vol. 257, no. 2, pp. 265–268, 1997
  113. Preclinical activity of trans-indazolium [tetrachlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cells
    European Journal of Cancer, vol. 33, no. 14, pp. 2404–2410, 1997
  114. STRUCTURE OF 4-HYDROXYPHENYLARSONIC ACID AND 4-METHOXY-3-NITROPHENYLARSONIC ACID
    Phosphorus, Sulfur, and Silicon and the Related Elements, vol. 118, no. 1, pp. 31–38, 1996
  115. PREPARATION OF OCTAETHYL-3-AMINO-PENTANE-1,1,5,5-TETRAKISPHOSPHONATE BY CATALYTIC HYDROGENATION OF THE CORRESPONDING 3-NITRO-COMPOUND
    Phosphorus, Sulfur, and Silicon and the Related Elements, vol. 112, no. 1, pp. 137–141, 1996
  116. Comparison of the Antiproliferative Activity of Two Antitumour Ruthenium(III) Complexes With Their Apotransferrin and Transferrin-Bound Forms in a Human Colon Cancer Cell Line
    Metal-Based Drugs, vol. 3, no. 1, pp. 15–23, 1996
  117. Synthesis, Characterization and Solution Chemistry of trans-Indazoliumtetrachlorobis(Indazole)Ruthenate(III), a New Anticancer Ruthenium Complex. IR, UV, NMR, HPLC Investigations and Antitumor Activity. Crystal Structures of trans-1-Methyl-Indazoliumtetrachlorobis-(1-Methylindazole)Ruthenate(III) and its Hydrolysis Product trans-Monoaquatrichlorobis-(1-Methylindazole)-Ruthenate(III)
    Metal-Based Drugs, vol. 3, no. 5, pp. 243–260, 1996
  118. Two antitumour ruthenium(III) complexes showing selectivity in their binding towards poly(dG)·poly(dC) and poly(dA)·poly(dT)
    Chemical Communications, no. 15, p. 1741, 1996
  119. Determination of platinum in protein-bound CDDP and DBP by inductively coupled plasma optical emission spectrometry and electrothermal atomic absorption spectrometry
    Journal of Analytical Atomic Spectrometry, vol. 11, no. 9, p. 747, 1996
  120. Binding of ruthenium(III) anti-tumor drugs to human lactoferrin probed by high resolution X-ray crystallographic structure analyses
    Journal of Biological Inorganic Chemistry, vol. 1, no. 5, pp. 424–431, 1996
  121. Synthesis and Structure of Seven-Coordinate Bismuth(V) Complexes with Benzenoid and Non-Benzenoid Arene Ligands: Tri(aryl)tropolonatobismuth(V) Complexes
    Angewandte Chemie International Edition in English, vol. 35, no. 1, pp. 67–68, 1996
  122. Struktur von S-9,10-Dimethyl-1,3,5,7-tetraarsa-2,4,6,8-tetraoxaadamantan und 9,10-Diethyl-1,3,5,7-tetraarsa-2,4,6,8-tetraoxaadamantan
    Zeitschrift f�r anorganische und allgemeine Chemie, vol. 622, no. 6, pp. 1097–1100, 1996
  123. First Isolation of an Enol of a Carboxylic Acid by Complexation to an(Ethane-1,2-diamine)-platinum(II) Fragment
    Angewandte Chemie International Edition in English, vol. 34, no. 10, pp. 1103–1104, 1995
  124. Inorganic Chemistry, vol. 34, no. 10, pp. 2788–2790, 1995
  125. Inorganic Chemistry, vol. 33, no. 6, pp. 1127–1132, 1994
  126. Inorganic Chemistry, vol. 33, no. 15, pp. 3396–3400, 1994
  127. Structure of an Antineoplastic Platinum Complex with a Bipyridyl–Crown Ether
    Angewandte Chemie International Edition in English, vol. 33, no. 2, pp. 186–188, 1994
  128. Activity of two platinum-linked phosphonic acids against autochthonous rat colorectal cancer as well as in two human colon-cancer cell lines
    Cancer Chemotherapy and Pharmacology, vol. 30, no. 2, pp. 131–138, 1992
  129. Antineoplastic activity of three ruthenium derivatives against chemically induced colorectal carcinoma in rats
    Journal of Cancer Research and Clinical Oncology, vol. 118, no. 3, pp. 195–200, 1992
  130. Chemoresistance in rat ovarian tumours
    European Journal of Cancer and Clinical Oncology, vol. 27, no. 1, pp. 62–67, 1991
  131. Cisplatin-linked phosphonates in the treatment of the transplantable osteosarcoma in vitro and in vivo
    Cancer Treatment Reviews, vol. 17, no. 2-3, pp. 253–259, 1990
  132. New tumor-inhibiting metal complexes
    Cancer Treatment Reviews, vol. 17, no. 2-3, pp. 261–277, 1990
  133. Anticancer-agent-linked phosphonates with antiosteolytic and antineoplastic properties: a promising perspective in the treatment of bone-related malignancies?
    Journal of Cancer Research and Clinical Oncology, vol. 116, no. 4, pp. 341–350, 1990
  134. Sensitivity of rodent osteosarcoma clones to platinum-containing phosphonic acid complexes in vitro
    Journal of Cancer Research and Clinical Oncology, vol. 116, no. 5, pp. 453–458, 1990
  135. Therapeutic efficacy of two different cytostatic-linked phosphonates in combination with razoxane in the transplantable osteosarcoma of the rat
    Clinical & Experimental Metastasis, vol. 8, no. 4, pp. 345–359, 1990
  136. Paradoxical effect of dichlorobis(1-phenylbutane-1,3-dionato)molybdenum (IV), (Mo(bzac)2Cl2 on the growth of autochthonous chemically induced colorectal tumors in SD rats
    Cancer Letters, vol. 34, no. 3, pp. 325–330, 1987
  137. Efficacy of ?-diketonato complexes of titanium, zirconium, and hafnium against chemically induced autochthonous colonic tumors in rats
    Journal of Cancer Research and Clinical Oncology, vol. 113, no. 5, pp. 446–450, 1987
  138. Inorganic Chemistry, vol. 26, no. 6, pp. 844–846, 1987
  139. Inorganic Chemistry, vol. 26, no. 26, pp. 4366–4370, 1987
  140. Antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III)
    Journal of Cancer Research and Clinical Oncology, vol. 111, no. 2, pp. 166–168, 1986
  141. Antitumor activity of cis-dihalogenobis(1-phenyl-1,3-butanedionato)titanium(IV) compounds
    Journal of Cancer Research and Clinical Oncology, vol. 105, no. 1, pp. 109–110, 1983